| 产品名称: | Micromonospora viridifaciens Routien |
|---|---|
| 商品货号: | TS207471 |
| Strain Designations: | FD 23988 |
| Application: | Produces 37504 Production of the antibiotic 37,504 |
| Isolation: | Soil, Japan |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®: | no |
| Type Strain: | no |
| Medium: | ATCC® Medium 172: N-Z amine with soluble starch and glucose |
| Growth Conditions: | Temperature: 26.0°C |
| Name of Depositor: | Chas. Pfizer & Co., Inc. |
| U.S. Patent Number: | |
| References: | Celmer WD, et al. Antibiotic produced by a species of Micromonospora. US Patent 3,991,183 dated Nov 9 1976 |
| Cross References: | Nucleotide (GenBank) : E02375 Neuraminidase gene. Nucleotide (GenBank) : D01045 Micromonospora viridifaciens DNA for nedR protein and neuraminidase, complete cds. |